9/2/10,
Cepheid's TB, Drug-Resistance Assay Shines as POC Test in Developing...
Cepheid's Xpert MTB/RIF test received a vote of confidence for its ability to diagnose TB and rifampicin resistance in remote and resource-poor regions of the world, according to the results of a New England Journal of Medicine study.
read more
|
|
9/2/10,
FDA, NIH Team IDs Murine Leukemia Virus Genes in Blood of Chronic...
The findings support a prior study that identified a similar virus in many CFS sufferers. However, it also conflicts with the results of several other studies that failed to detect gene sequences from either virus in CFS patients, raising questions about the PCR methods employed.
read more
|
|
9/2/10,
Q&A: UNCs Webster-Cyriaque Discusses qPCR Assay for Common HPV...
The assay may provide insight into the relationships between various HPV types and their associated diseases ? not just cervical cancer, but also potentially head and neck cancers and HPV-associated warts.
read more
|
9/1/10,
Third generation map of human genetic variation published
An international consortium publishes a third-generation map of human genetic variation, called the HapMap, which includes data from an additional seven global populations, increasing the total number to 11 populations. The improved resolution will help researchers interpret current genome studies aimed at finding common and rarer genetic variants associated with complex diseases.  |
|
9/1/10,
IP Update: Recent Patents Related to PCR, Nucleic Acid Amplification,...
Roche, Harvard University, Gen-Probe, U of Arkansas, Samsung, Quest, Eyetech, Novartis, Idaho Tech, University of Utah, and Mayo Clinic awarded US patents.
read more
|
|
9/1/10,
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
Abbott gets FDA nod for RealTime HBV assay; Asuragen launches KRAS and BRAF mutational testing services.
read more
|
|
9/1/10,
Product Watch
|
|
9/1/10,
People in the News
Matthew McManus named CEO of PrimeraDx; John Wineman and Thomas Vasicek join HTG.
read more
|
|
8/30/10,
NHGRI selects new scientific director for intramural research
Daniel L. Kastner, M.D., Ph.D.,has been selected to be the Scientific Director of the National Human Genome Research Institute (NHGRI), NHGRI Director Eric D. Green, M.D., Ph.D., announced. Dr. Kastner currently serves as Clinical Director and Director of Translational Research at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). NHGRI and NIAMS are two of the 27 institutes and centers that make up the National Institutes of Health. Dr. Kastner will assume his position at NHGRI in early October.  |
|
8/26/10,
QuantaLife Wins $820K from NIH to Develop MRSA Test for Digital PCR...
QuantaLife has been awarded $820,000 in the first year of a five-year project with the University of Mississippi Medical Center to develop microdroplet PCR-based point-of-care tests to detect methicillin-resistant Staphylococcus aureus.
read more
|
|
8/26/10,
Focus Diagnostics Awaits CE Mark, FDA Clearance for Combined Flu/RSV...
Focus and 3M are also developing a version of the influenza A/B/RSV test, as well as a test for herpes simplex virus, that would be suitable for use in moderate-complexity laboratories under the Clinical Laboratory Improvement Amendments act.
read more
|
|
8/26/10,
Enzo's Pennsylvania License Could Expand Market for GeneNews Colon...
Enzo has been awarded a license to provide clinical diagnostic services in Pennsylvania, which could help the eventual uptake of ColonSentry, a PCR-based colon cancer risk-stratification test manufactured by Canadian firm GeneNews and for which Enzo has exclusive distribution rights in New York and New Jersey.
read more
|
|
8/26/10,
Rheonix Wins $233K NIAID Grant to Add UTI Detection to Multiplex STD...
The long-term goal of the project is to develop a single test for detecting an array of STDs and UTIs using Rheonix's fully automated point-of-care molecular diagnostic platform, called CARD.
read more
|
Manual and Documents
